Book contents
- High-Risk Pregnancy: Management Options
- High-Risk Pregnancy: Management Options
- Copyright page
- Contents
- Contributors
- Section 1 Prepregnancy Problems
- Section 2 Early Prenatal Problems
- Section 3 Late Prenatal – Fetal Problems
- Section 4 Problems Associated with Infection
- Chapter 24 Hepatitis Virus Infections in Pregnancy (Content last reviewed: 23rd July 2019)
- Chapter 25 Human Immunodeficiency Virus in Pregnancy (Content last reviewed: 23rd July 2019)
- Chapter 26 Rubella, Measles, Mumps, Varicella, and Parvovirus in Pregnancy (Content last reviewed: 11th November 2020)
- Chapter 27 Cytomegalovirus, Herpes Simplex Virus, Adenovirus, Coxsackievirus, and Human Papillomavirus in Pregnancy (Content last reviewed: 11th November 2020)
- Chapter 28 Parasitic Infections in Pregnancy (Content last reviewed: 15th June 2018)
- Chapter 29 Other Infectious Conditions in Pregnancy (Content last reviewed: 11th November 2020)
- Section 5 Late Pregnancy – Maternal Problems
- Section 6 Late Prenatal – Obstetric Problems
- Section 7 Postnatal Problems
- Section 8 Normal Values
- Index
- References
Chapter 27 - Cytomegalovirus, Herpes Simplex Virus, Adenovirus, Coxsackievirus, and Human Papillomavirus in Pregnancy (Content last reviewed: 11th November 2020)
Published online by Cambridge University Press: 15 November 2017
Book contents
- High-Risk Pregnancy: Management Options
- High-Risk Pregnancy: Management Options
- Copyright page
- Contents
- Contributors
- Section 1 Prepregnancy Problems
- Section 2 Early Prenatal Problems
- Section 3 Late Prenatal – Fetal Problems
- Section 4 Problems Associated with Infection
- Chapter 24 Hepatitis Virus Infections in Pregnancy (Content last reviewed: 23rd July 2019)
- Chapter 25 Human Immunodeficiency Virus in Pregnancy (Content last reviewed: 23rd July 2019)
- Chapter 26 Rubella, Measles, Mumps, Varicella, and Parvovirus in Pregnancy (Content last reviewed: 11th November 2020)
- Chapter 27 Cytomegalovirus, Herpes Simplex Virus, Adenovirus, Coxsackievirus, and Human Papillomavirus in Pregnancy (Content last reviewed: 11th November 2020)
- Chapter 28 Parasitic Infections in Pregnancy (Content last reviewed: 15th June 2018)
- Chapter 29 Other Infectious Conditions in Pregnancy (Content last reviewed: 11th November 2020)
- Section 5 Late Pregnancy – Maternal Problems
- Section 6 Late Prenatal – Obstetric Problems
- Section 7 Postnatal Problems
- Section 8 Normal Values
- Index
- References
Summary
In an immunocompetent adult, viral infections may be asymptomatic or cause only mild nonspecific symptoms, but they can pose a serious threat to the fetus and the newborn.
- Type
- Chapter
- Information
- High-Risk PregnancyManagement Options, pp. 659 - 694Publisher: Cambridge University PressFirst published in: 2017
References
Gouarin, S, Gault, E, Vabret, A, et al. Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J Clin Microbiol 2002; 40: 1767–72.
Lazzarotto, T, Varani, S, Guerra, B, et al. Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 2000; 137: 90–5.
Revello, MG, Zavattoni, M, Furione, M, Baldanti, F, Gerna, G. Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses. J Clin Microbiol 1999; 37: 3350–2.
Barbi, M, Binda, S, Caroppo, S, et al. Multicity Italian study of congenital cytomegalovirus infection. Pediatr Infect Dis J 2006; 25: 156–9.
Reddy, UM, Baschat, AA, Zlatnik, MG, et al. Detection of viral deoxyribonucleic acid in amniotic fluid: association with fetal malformation and pregnancy abnormalities. Fetal Diagn Ther 2005; 20: 203–7.
Picone, O, Costa, JM, Leruez-Ville, M, et al. Cytomegalovirus (CMV) glycoprotein B genotype and CMV DNA load in the amniotic fluid of infected fetuses. Prenat Diagn 2004; 24: 1001–6.
Baschat, AA, Towbin, J, Bowles, NE, Harman, CR, Weiner, CP. Prevalence of viral DNA in amniotic fluid of low-risk pregnancies in the second trimester. J Matern Fetal Neonatal Med 2003; 13: 381–4.
Walter, S, Atkinson, C, Sharland, M, et al. Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss. Arch Dis Child Fetal Neonatal Ed 2008; 93: F280–5.
Kumazaki, K, Ozono, K, Yahara, T, et al. Detection of cytomegalovirus DNA in human placenta. J Med Virol 2002; 68: 363–9.
Folkins, AK, Chisholm, KM, Guo, FP, et al. Diagnosis of congenital CMV using PCR performed on formalin-fixed, paraffin-embedded placental tissue. Am J Surg Pathol 2013; 37: 1413–20.
Pereira, L, Maidji, E. Cytomegalovirus infection in the human placenta: maternal immunity and developmentally regulated receptors on trophoblasts converge. Curr Top Microbiol Immunol 2008; 325: 383–95.
Maidji, E, McDonagh, S, Genbacev, O, Tabata, T, Pereira, L. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol 2006; 168: 1210–26.
Chou, S. Newer methods for diagnosis of cytomegalovirus infection. Rev Infect Dis 1990; 12 (Suppl 7): S727–36.
Lazzarotto, T, Guerra, B, Lanari, M, Gabrielli, L, Landini, MP. New advances in the diagnosis of congenital cytomegalovirus infection. J Clin Virol 2008; 41: 192–7.
Guerra, B, Simonazzi, G, Banfi, A, et al. Impact of diagnostic and confirmatory tests and prenatal counseling on the rate of pregnancy termination among women with positive cytomegalovirus immunoglobulin M antibody titers. Am J Obstet Gynecol 2007; 196: 221.e1–6.
Revello, MG, Fabbri, E, Furione, M, et al. Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience. J Clin Virol 2011; 50: 303–7. doi: 10.1016/j.jcv.2010.12.012.
Lazzarotto, T, Guerra, B, Gabrielli, L, Lanari, M, Landini, MP. Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clin Microbiol Infect 2011; 17: 1285–93. doi: 10.1111/j.1469-0691.2011.03564.x.
Griffiths, PD, Stagno, S, Pass, RF, Smith, RJ, Alford, CA. Infection with cytomegalovirus during pregnancy: specific IgM antibodies as a marker of recent primary infection. J Infect Dis 1982; 145: 647–53.
Ruellan-Eugene, G, Barjot, P, Campet, M, et al. Evaluation of virological procedures to detect fetal human cytomegalovirus infection: avidity of IgG antibodies, virus detection in amniotic fluid and maternal serum. J Med Virol 1996; 50: 9–15.
Lazzarotto, T, Varani, S, Spezzacatena, P, et al. Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol 2000; 13: 137–41.
Bodeus, M, Van Ranst, M, Bernard, P, Hubinont, C, Goubau, P. Anticytomegalovirus IgG avidity in pregnancy: a 2-year prospective study. Fetal Diagn Ther 2002; 17: 362–6.
Revello, MG, Lilleri, D, Zavattoni, M, et al. Human cytomegalovirus immediate-early messenger RNA in blood of pregnant women with primary infection and of congenitally infected newborns. J Infect Dis 2001; 184: 1078–81.
Tanimura, K, Yamada, H. Potential biomarkers for predicting congenital cytomegalovirus infection. Int J Mol Sci 2018; 19: 3760. doi: 10.3390/ijms19123760.
Azam, AZ, Vial, Y, Fawer, CL, Zufferey, J, Hohlfeld, P. Prenatal diagnosis of congenital cytomegalovirus infection. Obstet Gynecol 2001; 97: 443–8.
Nigro, G, Mazzocco, M, Anceschi, MM, et al. Prenatal diagnosis of fetal cytomegalovirus infection after primary or recurrent maternal infection. Obstet Gynecol 1999; 94: 909–14.
Grose, C, Weiner, CP. Prenatal diagnosis of congenital cytomegalovirus infection: two decades later. Am J Obstet Gynecol 1990; 163: 447–50.
Van den Veyver, IB, Ni, J, Bowles, N, et al. Detection of intrauterine viral infection using the polymerase chain reaction. Mol Genet Metab 1998; 63: 85–95.
Lamy, ME, Mulango, KN, Gadisseux, JF, et al. Prenatal diagnosis of fetal cytomegalovirus infection. Am J Obstet Gynecol 1992; 166: 91–4.
Liesnard, C, Donner, C, Brancart, F, et al. Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol 2000; 95: 881–8.
Hogge, WA, Buffone, GJ, Hogge, JS. Prenatal diagnosis of cytomegalovirus (CMV) infection: a preliminary report. Prenat Diagn 1993; 13: 131–6.
Xu, W, Sundqvist, V-A, Brytting, M, Linde, A. Diagnosis of cytomegalovirus infections using polymerase chain reaction, virus isolation and serology. Scand J Infect Dis 1993; 25: 311–16.
Catanzarite, V, Dankner, WM. Prenatal diagnosis of congenital cytomegalovirus infection: false-negative amniocentesis at 20 weeks’ gestation. Prenat Diagn 1993; 13: 1021–5.
Revello, MG, Gerna, G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002; 15: 680–715. doi: 10.1128/CMR.15.4.680-715.2002.
Revello, MG, Baldanti, F, Furione, M, et al. Polymerase chain reaction for prenatal diagnosis of congenital human cytomegalovirus infection. J Med Virol 1995; 47: 462–6.
Lynch, L, Daffos, F, Emanuel, D, et al. Prenatal diagnosis of fetal cytomegalovirus infection. Am J Obstet Gynecol 1991; 165: 714–18.
Watt-Morse, ML, Laifer, SA, Hill, LM. The natural history of fetal cytomegalovirus infection as assessed by serial ultrasound and fetal blood sampling: a case report. Prenat Diagn 1995; 15: 567–70.
Peters, MT, Lowe, TW, Carpenter, A, Kole, S. Prenatal diagnosis of congenital cytomegalovirus infection with abnormal triple-screen results and hyperechoic fetal bowel. Am J Obstet Gynecol 1995; 173: 953–4.
Lipitz, S, Achiron, R, Zalel, Y, et al. Outcome of pregnancies with vertical transmission of primary cytomegalovirus infection. Obstet Gynecol 2002; 100: 428–33.
Guerra, B, Simonazzi, G, Puccetti, C, et al. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2008; 198: 380.e1–7.
Lipitz, S, Hoffmann, C, Feldman, B, et al. Value of prenatal ultrasound and magnetic resonance imaging in assessment of congenital primary cytomegalovirus infection. Ultrasound Obstet Gynecol 2010; 36: 709–17.
Benoist, G, Salomon, LJ, Mohlo, M, et al. Cytomegalovirus-related fetal brain lesions: comparison between targeted ultrasound examination and magnetic resonance imaging. Ultrasound Obstet Gynecol 2008; 32: 900–5.
Picone, O, Simon, I, Benachi, A, Brunelle, F, Sonigo, P. Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection. Prenat Diagn 2008; 28: 753–8.
Hadar, E, Dorfman, E, Bardin, R, et al. Symptomatic congenital cytomegalovirus disease following non-primary maternal infection: a retrospective cohort study. BMC Infect Dis 2017; 17: 31. doi: 10.1186/s12879-016-2161-3.
Stagno, S, Pass, RF, Dworsky, ME, Alford, CA. Congenital and perinatal cytomegalovirus infection. Semin Perinatol 1983; 7: 31–42.
Raynor, BD. Cytomegalovirus infection in pregnancy. Semin Perinatol 1993; 17: 394–402.
Slyker, JA, Lohman-Payne, BL, Rowland-Jones, SL, et al. The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1–infected woman and their infants. AIDS 2009; 23: 117–24.
Chretien, JH, McGinnis, CG, Muller, A. Venereal causes of cytomegalovirus mononucleosis. JAMA 1977; 238: 1644–5.
Chandler, SH, Handsfield, HH, McDougall, JK. Isolation of multiple strains of cytomegalovirus from women attending a clinic for sexually transmitted diseases. J Infect Dis 1987; 155: 655–60.
Yeager, AS, Grumet, FC, Hafleigh, EB, et al. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr 1981; 98: 281–7.
Hersman, J, Meyers, JD, Thomas, ED, Buckner, CD, Clift, R. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med 1982; 96: 149–52.
Stagno, S, Reynolds, DW, Pass, RF, Alford, CA. Breast milk and the risk of cytomegalovirus infection. N Engl J Med 1980; 302: 1073–6.
Miron, D, Brosilow, S, Felszer, K, et al. Incidence and clinical manifestations of breast milk–acquired cytomegalovirus infection in low birth weight infants. J Perinatol 2005; 25: 299–303.
Doctor, S, Friedman, S, Dunn, MS, et al. Cytomegalovirus transmission to extremely low-birthweight infants through breast milk. Acta Paediatr 2005; 94: 53–8.
Gurevich, I, Cunha, BA. Nonparenteral transmission of cytomegalovirus in a neonatal intensive care unit. Lancet 1981; ii: 222–4.
Marshall, BC, Adler, SP. The frequency of pregnancy and exposure to cytomegalovirus infections among women with a young child in day care. Am J Obstet Gynecol 2009; 200: 163.e1–5.
Pass, RF, Little, EA, Stagno, S, Britt, WJ, Alford, CA. Young children as a probable source of maternal and congenital cytomegalovirus infection. N Engl J Med 1987; 316: 1366–70.
Staras, SA, Dollard, SC, Radford, KW, et al. Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis 2006; 43: 1143–51.
Cannon, MJ. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol 2009; 46 (Suppl 4): S6–10.
Krech, U. Complement-fixing antibodies against cytomegalovirus in different parts of the world. Bull WHO 1973; 49: 103–6.
Stagno, S, Pass, RF, Cloud, G, et al. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to the fetus, and clinical outcome. JAMA 1986; 256: 1904–8.
Tookey, PA, Ades, AE, Peckham, CS. Cytomegalovirus prevalence in pregnant women: the influence of parity. Arch Dis Child 1992; 67: 779–83.
Peckham, CS, Coleman, JC, Hurley, R, et al. Cytomegalovirus infection in pregnancy: preliminary findings from a prospective study. Lancet 1983; i: 1352–5.
Colugnati, FA, Staras, SA, Dollard, SC, Cannon, MJ. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis 2007; 7: 71.
Yow, MD, Williamson, DW, Leeds, LJ, et al. Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am J Obstet Gynecol 1988; 158: 1189–95.
Kenneson, A, Cannon, MF. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007; 17: 253–76.
Griffiths, PD, Campbell-Benzie, A, Heath, RB. A prospective study of primary cytomegalovirus infection in pregnant women. Br J Obstet Gynaecol 1980; 87: 308–14.
Stagno, S, Whitley, RJ. Herpesvirus infections of pregnancy. Part I: cytomegalovirus and Epstein–Barr virus infections. N Engl J Med 1985; 313: 1270–4.
Crumpacker, CS. Cytomegalovirus. In Mandell, GL, Douglas, RG, Bennett, JE (eds), Principles and Practice of Infectious Diseases, 5th edn. New York, NY: Churchill Livingstone, 2000, pp. 1586–99.
Arora, N, Novak, Z, Fowler, KB, Boppana, SB, Ross, SA. Cytomegalovirus viruria and DNAemia in healthy seropositive women. J Infect Dis 2010; 202: 1800–3.
Ross, SA, Arora, N, Novak, Z, et al. Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis 2010; 201: 386–9.
Wang, C, Zhang, X, Bialek, S, Cannon, MJ. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis 2011; 52: e11–13.
Stagno, S. Cytomegalovirus. In Remington, JS, Klein, JO (eds), Infectious Diseases of the Fetus and Newborn Infant, 5th edn. Philadelphia, PA: Saunders, 2001, pp. 389–424.
Picone, O, Vauloup-Fellous, C, Cordier, AG, et al. A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenat Diagn 2013; 33: 751–8.
Giannattasio, A, Di Costanzo, P, Matteis, De, et al. Outcomes of congenital cytomegalovirus disease following maternal primary and non-primary infection. J Clin Virol 2017; 96: 32–6. doi: 10.1016/j.jcv.2017.09.006.
Puhakka, L, Renko, M, Helminen, M, et al. Primary versus non-primary maternal cytomegalovirus infection as a cause of symptomatic congenital infection: register-based study from Finland. Infect Dis 2017; 49: 445–53. doi: 10.1080/23744235.2017.1279344.
Manicklal, S, Emery, VC, Lazzarotto, T, Boppana, SB, Gupta, RK. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 2013; 26: 86–102. doi: 10.1128/CMR.00062-12.
Marsico, C, Kimberlin, DW. Congenital cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Pediatr 2017; 43: 38. doi: 10.1186/s13052-017-0358-8.
Stagno, S. Cytomegalovirus. In Remington, JS, Klein, JO (eds), Infectious Diseases of the Fetus and Newborn Infant, 4th edn. Philadelphia, PA: Saunders, 1995, pp. 312–53.
Demmler, GJ. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 1991; 13: 315–29.
Fowler, KB, McCollister, FP, Dahle, AJ, et al. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997; 130: 624–30.
Boppana, SB, Rivera, LB, Fowler, KB, Mach, M, Britt, WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001; 344: 1366–71.
Fowler, KB, Stagno, S, Pass, RF, et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992; 326: 663–7.
Hicks, T, Fowler, K, Richardson, M, et al. Congenital cytomegalovirus infection and neonatal auditory screening. J Pediatr 1993; 123: 779–82.
Ahlfors, K, Ivarsson, SA, Bjerre, I. Microcephaly and congenital cytomegalovirus infection: a combined prospective and retrospective study of a Swedish infant population. Pediatrics 1986; 78: 1058–63.
Centers for Disease Control and Prevention (CDC). Knowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy: United States, 2007. MMWR Morb Mortal Wkly Rep 2008; 57: 65–8.
Ross, DS, Dollard, SC, Victor, M, Sumartojo, E, Cannon, MJ. The epidemiology and prevention of congenital cytomegalovirus infection and disease Activities of the Centers for Disease Control and Prevention Workgroup. J Womens Health (Larchmt) 2006; 15: 224–9.
Cannon, MF, Davis, KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 2005; 5: 70.
Ross, DS, Victor, M, Sumartojo, E, Cannon, MJ. Women’s knowledge of congenital cytomegalovirus: results from the 2005 Health Styles survey. J Womens Health (Larchmt) 2008; 17: 849–58.
Piper, J, Wen, TS. Perinatal cytomegalovirus and toxoplasmosis: challenges of antepartum therapy. Clin Obstet Gynecol 1999; 42: 81–96.
American College of Obstetricians and Gynecologists. Practice bulletin no. 151: cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy. Obstet Gynecol 2015; 125: 1510–25.
Griffiths, PD, McLean, A, Emery, VC. Encouraging prospects for immunisation against primary cytomegalovirus infection. Vaccine 2001; 19: 1356–62.
Cheeran, MC, Lokensgard, JR, Schleiss, MR. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev 2009; 22: 99–126.
Pass, RF, Zhang, C, Evans, A, et al. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009; 360: 1191–9.
Dasari, V, Smith, C, Zhong, J, et al. Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus. J Gen Virol 2011; 92: 1021–31.
Sabbaj, S, Pass, RF, Goepfert, PA, Pichon, S. Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women. J Infect Dis 2011; 203: 1534–41.
Adler, SP. Cytomegalovirus and child day care. Evidence for an increased infection rate among day-care workers. N Engl J Med 1989; 321: 1290–6.
McGregor, JA, Rubright, G, Ogle, JW. Congenital cytomegalovirus infection as a preventable complication of maternal transfusion. A case report. J Reprod Med 1990; 35: 61–4.
Revello, MG, Rercivalle, E, Baldanti, F, et al. Prenatal treatment of congenital human cytomegalovirus infection by fetal intravascular administration of ganciclovir. Clin Diagn Virol 1993; 1: 61–7.
Puliyanda, DP, Silverman, NS, Lehman, D, et al. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient. Transpl Infect Dis 2005; 7: 71–4.
Jacquemard, F, Yamamoto, M, Costa, JM, et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 2007; 114: 1113–21.
Leruez-Ville, M, Ghout, I, Bussières, L, et al. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am J Obstet Gynecol 2016; 215: 462.e1–10.
Kimberlin, DW, Jester, PM, Sánchez, PJ, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 2015; 372: 933–43.
Nigro, G, Adler, SP, La Torre, R, et al. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005; 353: 1350–62.
Nigro, G, Torre, RL, Pentimalli, H, et al. Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Prenat Diagn 2008; 28: 512–17.
Moxley, K, Knudtson, EJ. Resolution of hydrops secondary to cytomegalovirus after maternal and fetal treatment with human cytomegalovirus hyperimmune globulin. Obstet Gynecol 2008; 111: 524–6.
Nigro, G, Adler, SP, Parruti, G, et al. Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy: a case-control study of the outcome in children. J Infect Dis 2012; 205: 215–27.
Visentin, S, Manara, R, Milanese, L, et al. Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. Clin Infect Dis 2012; 55: 497–503.
Revello, MG, Lazzarotto, T, Guerra, B, et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med 2014; 370: 1316–26.
Minsart, AF, Smiljkovic, M, Renaud, C, et al. Use of cytomegalovirus-specific hyperimmunoglobulins in pregnancy: a retrospective cohort. J Obstet Gynaecol Can 2018; 40: 1409–16. doi: 10.1016/j.jogc.2018.03.013.
Kimberlin, DW, Lin, CY, Sanchez, PJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized controlled trial. J Pediatr 2003; 143: 16–25.
Oliver, SE, Cloud, GA, Sánchez, PJ, et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol 2009; 46 (Suppl 4): S22–6.
Ryder, N, Jin, F, McNulty, AM, Grulich, AE, Donovan, B. Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992–2006. Sex Transm Infect 2009; 85: 416–19.
Bernstein, DI, Bellamy, AR, Hook, EW, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis 2013; 56: 344–51.
Landy, HJ, Grossman, JH. Herpes simplex virus. Obstet Gynecol Clin North Am 1989; 16: 495–515.
Wald, A, Huang, ML, Carrell, D, Selke, S, Corey, L. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis 2003; 188: 1345–51.
Van Der Pol, B, Warren, T, Taylor, SN, et al. Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test. J Clin Microbiol 2012; 50: 3466–71.
Cone, RW, Hobson, AC, Brown, ZA, et al. Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA 1994; 272: 792–6.
Workowski, KA, Bolan, GA; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64 (RR-03): 1–137.
Ashley, RL. Sorting out the new HSV type specific antibody tests. Sex Transm Infect 2001; 77: 232–7.
Morrow, R, Friedrich, D. Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection. Clin Microbiol Infect 2006; 12: 463–9.
Brown, ZA. Case study: type-specific HSV serology and the correct diagnosis of first-episode genital herpes during pregnancy. Herpes 2002; 9: 24–6.
Koutsky, LA, Stevens, CE, Holmes, KK, et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 1992; 326: 1533–9.
Arvin, AM, Hensleigh, PA, Prober, CG, et al. Failure of antepartum maternal culture to predict the infant’s risk of exposure to herpes simplex virus at delivery. N Engl J Med 1986; 315: 796–800.
Riley, LE. Herpes simplex virus. Semin Perinatol 1998; 22: 284–92.
Rouse, DJ, Stringer, JSA. An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes. Am J Obstet Gynecol 2000; 183: 400–6.
Kulhanjian, JA, Soroush, V, Au, DS, et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med 1992; 326: 916–20.
Corey, L, Wald, A, Patel, R, et al. Once daily valacyclovir reduces transmission of genital herpes. N Engl J Med 2004; 350: 11–20.
Baker, DA, Amstey, MS. Herpes simplex virus: biology, epidemiology, and clinical infection. Semin Perinatol 1983; 7: 1–8.
Rooney, JF, Felser, JM, Ostrove, JM, Straus, SE. Acquisition of genital herpes from an asymptomatic sexual partner. N Engl J Med 1986; 314: 1561–4.
Koelle, DM, Benedetti, J, Langenberg, A, Corey, L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med 1992; 116: 433–7.
Whitley, RJ, Soong, SJ, Linneman, C, et al. Herpes simplex encephalitis. Clinical assessment. JAMA 1982; 247: 317–20.
Rubin, MH, Ward, DM, Painter, CJ. Fulminant hepatic failure caused by genital herpes in a healthy person. JAMA 1985; 253: 1299–301.
Laffery, WE, Coombs, RW, Benedetti, J, Critchlow, C, Corey, L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1987; 316: 1444–9.
Fleming, DT, McQuillan, GM, Johnson, RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 16: 1105–10.
Mertz, GL, Benedetti, J, Ashley, R, Selke, SA, Corey, L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116: 197–202.
Amstrong, GL, Schillinger, J, Markowitz, L, et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol 2001; 153: 912–20.
Brown, ZA, Selke, S, Zeh, J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997; 337: 509–15.
Gonik, B, Loo, LS, West, S, Kohl, S. Natural killer cell cytotoxicity and antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells in human pregnancy. Am J Reprod Immunol Microbiol 1987; 13: 23–6.
Lagrew, DC, Furlow, TG, Hager, WD, Yarrish, RL. Disseminated herpes simplex virus infection in pregnancy. Successful treatment with acyclovir. JAMA 1984; 252: 2058–9.
Whitley, RJ, Corey, L, Arvin, A, et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 1988; 158: 109–16.
Brown, ZA, Benedetti, J, Ashley, R, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991; 324: 1247–52.
Brown, ZA, Vontver, LA, Benedetti, J, et al. Effects on infants of a first episode of genital herpes during pregnancy. N Engl J Med 1987; 317: 1246–51.
Brown, ZA, Wald, A, Morrow, RA, et al. Effect of serologic status and caesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289: 203–9.
Catalono, PM, Meritt, AO, Mead, PB. Incidence of genital herpes simplex virus at the time of delivery in women with known risk factors. Am J Obstet Gynecol 1991; 164: 1303–6.
Stone, KM, Brooks, CA, Guinan, ME, Alexander, ER. National surveillance for neonatal herpes simplex virus infections. Sex Transm Dis 1989; 16: 152–6.
Kerkering, K, Gardella, C, Selke, S, et al. Isolation of herpes simplex virus from the genital tract during symptomatic recurrence on the buttocks. Obstet Gynecol 2006; 108: 947–52.
Whitley, R, Arvin, A, Prober, C, et al. Predictors of morbidity and mortality in neonates with herpes simplex infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991; 324: 450–4.
Looker, KJ, Magaret, AS, May, MT, et al. First estimates of the global and regional incidence of neonatal herpes infection. Lancet Glob Health 2017; 5: e300–9. doi: 10.1016/S2214-109X(16)30362-X.
Casper, C, Wald, A. Condom use and the prevention of genital herpes acquisition. Herpes 2002; 9: 10–14.
Scott, LL, Sanchez, PJ, Jackson, GL, Zeray, F, Wendel, GD. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 1996; 87: 69–73.
Centers for Disease Control and Prevention (CDC). Pregnancy outcomes following systemic acyclovir exposure. June 1, 1984–June 30, 1993. MMWR Morb Mortal Wkly Rep 1993; 42: 806–9.
Stone, KM, Reiff-Eldridge, R, White, AD, et al. Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the International Acyclovir Pregnancy Registry, 1984–1999. Birth Defects Res A Clin Mol Teratol 2004; 70: 201–7.
Fife, KH, Crumpacker, CS, Mertz, GJ, Hill, EL, Boone, GS. Recurrence and resistance patterns of herpes simplex virus following cessation of ≥ 6 years of chronic suppression with acyclovir. Acyclovir Study Group. J Infect Dis 1994; 169: 1338–41.
Reyes, M, Shaik, NS, Graber, JM, et al. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med 2003; 163: 76–80.
Levin, MJ, Bacon, TH, Leary, JJ. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients. Clin Infect Dis 2004; 39 (Suppl 5): S248–257.
Frenkel, LM, Brown, ZA, Bryson, YJ, et al. Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol 1991; 164: 569–76.
Sheffield, JS, Hollier, LM, Hill, JB, Stuart, GS, Wendel, GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol 2003; 102: 1396–403.
Sheffield, JS, Wendel, GD, Laibl, V, et al. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized controlled trial. Obstet Gynecol 2006; 108: 1550–2.
American College of Obstetricians and Gynecologists. Management of Herpes in Pregnancy ACOG Practice Bulletin No. 8. Washington, DC: ACOG, 1999.
American College of Obstetricians and Gynecologists. Management of Herpes in Pregnancy ACOG Practice Bulletin No. 82. Washington, DC: ACOG, 2007.
Baker, D, Brown, Z, Hollier, LM, et al. Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy. Am J Obstet Gynecol 2004; 191: 2074–84.
Major, CA, Towers, CV, Lewis, DF, Garite, TJ. Expectant management of preterm premature rupture of membranes complicated by active recurrent genital herpes. Am J Obstet Gynecol 2003; 188: 1551–4.
Goldkrand, JW. Intrapartum inoculation of herpes simplex virus by fetal scalp electrode. Obstet Gynecol 1982; 59: 263–5.
Hollier, LM, Scott, LL, Murphree, SS, Wendel, GD. Postpartum endometritis caused by herpes simplex virus. Obstet Gynecol 1997; 89: 836–8.
Larson, JE, Morrow, SL, Happel, L, Sharp, JF, Cohen, JC. Reversal of cystic fibrosis phenotype in mice by gene therapy in utero. Lancet 1997; 349: 619–20.
Kita, Y, Li, XK, Ohba, M, et al. Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLA4IG-gene. Transplantation 1999; 68: 758–66.
Schneider, H, Muehle, C, Douar, AM, et al. Sustained delivery of therapeutic concentrations of human clotting factor IX: a comparison of adenoviral and AAV vectors administered in utero. J Gene Med 2002; 4: 46–53.
Yano, K, Liaw, PC, Mullington, JM, et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 2006; 203: 1447–58.
Lu, F, Bytautiene, E, Tamayo, E, et al. Gender-specific effect of overexpression of sFit-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. Am J Obstet Gynecol 2007; 197: 418.e1–5.
Sylvester, KG, Yang, EY, Cass, DL, Crombleholme, TM, Adzick, NS. Fetoscopic gene therapy for congenital lung disease. J Pediatr Surg 1997; 32: 964–9.
Baumgartner, TL, Baumgartner, BJ, Hudon, L, Moise, KJ. Ultrasonographically guided direct gene transfer in utero: successful induction of beta-galactosidase in a rabbit model. Am J Obstet Gynecol 1999; 181: 848–52.
Iwamoto, HS, Trapnell, BC, McConnell, CJ, Daugherty, C, Whitsett, JA. Pulmonary inflammation associated with repeated, prenatal exposure to an E1, E3-deleted adenoviral vector in sheep. Gene Ther 1999; 6: 98–106.
Xing, A, Boileau, P, Caüzac, M, et al. Comparative in vivo approaches for selective adenovirus-mediated gene delivery to the placenta. Hum Gene Ther 2000; 11: 167–77.
David, AL, Torondel, B, Zachary, I, et al. Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep. Gene Ther 2008; 15: 1344–50.
Grisafi, D, Piccoli, M, Pozzobon, M, et al. High transduction efficiency of human amniotic fluid stem cells mediated by adenovirus vectors. Stem Cells Dev 2008; 17: 953–62.
Horwitz, MS. Adenoviruses. In Fields, BN, Knipe, DM, Howley, PM (eds), Fields Virology, 3rd edn. Philadelphia, PA: Lippincott-Raven, 1995, pp. 2149–71.
Foy, HM. Adenoviruses. In Evans, A, Kaslow, R (eds), Viral Infection in Humans: Epidemiology and Control, 4th edn. New York, NY: Plenum, 1997, pp. 119–38.
Matsuoka, T, Naito, T, Kubato, Y, et al. Disseminated adenovirus (type 19) infection in a neonate: rapid detection of the infection by immunofluorescence. Acta Paediatr Scand 1990; 79: 568–71.
Montone, KT, Furth, EE, Pietra, GG, Gupta, PK. Neonatal adenovirus infection: a case report with in situ hybridization confirmation of ascending intrauterine infection. Diagn Cytopathol 1995; 12: 341–4.
Ranucci-Weiss, D, Uerpairojkit, B, Bowles, N, Towbin, JA, Chan, L. Intrauterine adenoviral infection associated with fetal nonimmune hydrops. Prenat Diagn 1998; 18: 182–5.
Towbin, JA, Griffin, LD, Martin, AB, et al. Intrauterine adenoviral myocarditis presenting as nonimmune hydrops fetalis: diagnosis by polymerase chain reaction. Pediatr Infect Dis J 1994; 13: 144–50.
Abzug, MJ, Levine, MJ. Neonatal adenovirus infection: four patients and review of the literature. Pediatrics 1991; 87: 890–6.
Angella, JJ, Connor, JD. Neonatal infection caused by adenovirus type 7. J Pediatr 1968; 72: 474–8.
Kinney, JS, Hierholzer, JC, Thibault, DW. Neonatal pulmonary insufficiency caused by adenovirus infection successfully treated with extracorporeal membrane oxygenation. J Pediatr 1994; 125: 110–12.
Brown, M, Rossier, E, Carpenter, B, Anand, CM. Fatal adenovirus type 35 infection in newborns. Pediatr Infect Dis J 1991; 10: 955–6.
Meyer, K, Girgis, N, McGravey, V. Adenovirus associated with congenital pleural effusions. J Pediatr 1985; 107: 433–5.
Finn, A, Anday, E, Talbot, GH. An epidemic of adenovirus 7a infection in a neonatal nursery: course, morbidity, and management. Infect Control Hosp Epidemiol 1988; 9: 398–404.
Carter, BA, Karpen, SJ, Quiros-Tejeira, RE, et al. Intravenous cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient. Transplantation 2002; 74: 1050–2.
Arav-Boger, R, Echavarria, M, Forman, M, Charache, P, Persaud, D. Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient. Pediatr Infect Dis J 2000; 19: 1097–100.
Ronchi, A, Doern, C, Brock, E, Pugni, L, Sánchez, PJ. Neonatal adenoviral infection: a seventeen year experience and review of the literature. J Pediatr 2014; 164: 529–35.
Prodhan, P, Bhutta, AT, Gossett, JM, et al. Extracorporeal membrane oxygenation support among children with adenovirus infection: a review of the Extracorporeal Life Support Organization registry. ASAIO J 2014; 60: 49–56.
Lyons, A, Longfield, J, Kuschner, R, et al. A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults. Vaccine 2008; 26: 2890–8.
Radin, JM, Hawksworth, AW, Blair, PJ, et al. Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines. Clin Infect Dis 2014; 59: 962–8.
Tindall, JP, Callaway, JL. Hand-foot-and-mouth disease: it’s more common than you think. Am J Dis Child 1972; 124: 372–5.
Zoll, GJ, Melchers, WJG, Kopecka, H, et al. General primer-mediated polymerase chain reaction for detection of enteroviruses: application for diagnostic routine and persistent infections. J Clin Microbiol 1992; 30: 160–5.
Pozzetto, B, Gaudin, OG, Aouni, M, Ros, A. Comparative evaluation of immunoglobulin M neutralizing antibody response in acute-phase sera and virus isolation for the routine diagnosis of enterovirus infection. J Clin Microbiol 1989; 27: 705–8.
Shin, SY, Kim, KS, Lee, YS, et al. Identification of enteroviruses by using monoclonal antibodies against a putative common epitope. J Clin Microbiol 2003; 41: 3028–34.
Cherry, JD, Krogstad, P. Enteroviruses. In Wilson, CB, Nizet, V, Maldonado, YA. Remington, JS, Klein, JO (eds), Infectious Diseases of the Fetus and Newborn Infant, 8th edn. Philadelphia, PA: Saunders, 2016, pp. 782–827.
Ettischer-Schmid, N, Normann, A, Sauter, M, et al. A new monoclonal antibody (Cox mAB 31A2) detects VP1 protein of coxsackievirus B3 with high sensitivity and specificity. Virchows Arch 2016; 469: 553–62.
Miao, LY, Pierce, C, Gray-Johnson, J, et al. Monoclonal antibodies to VP1 recognize a broad range of enteroviruses. J Clin Microbiol 2009; 47: 3108–13.
Redline, R, Genest, D, Tycko, B. Detection of enteroviral infection in paraffin-embedded tissue by the RNA polymerase chain reaction technique. Am J Clin Pathol 1991; 96: 568–71.
Modlin, JF. Perinatal echovirus and group B coxsackievirus infections. Clin Perinatol 1988; 15: 233–46.
Baker, DA, Phillips, CA. Maternal and neonatal infection with coxsackievirus. Obstet Gynecol 1980; 55 (Suppl 3): 12S–15S.
Archer, JS. Acute liver failure in pregnancy. J Reprod Med 2001; 46: 137–40.
Frisk, G, Diderholm, H. Increased frequency of coxsackie B virus IgM in women with spontaneous abortion. J Infect 1992; 24: 141–5.
Johansson, ME, Holmström, S, Abebe, A, et al. Intrauterine fetal death due to echovirus 11. Scand J Infect Dis 1992; 24: 381–5.
Modlin, JF. Fatal echovirus 11 disease in premature neonates. Pediatrics 1980; 66: 775–80.
Sever, JL, Huebner, RJ, Castellano, GA, Bell, JA. Serologic diagnosis “en masse” with multiple antigens. Am Rev Respir Dis 1963; 88: 342–9.
Cherry, JD, Soriano, F, Jahn, CL. Search for perinatal virus infection: a prospective, clinical, virologic and serologic study. Am J Dis Child 1968; 116: 245–50.
Kaplan, MH, Klein, SW, McPhee, J, Harper, RG. Group B coxsackievirus infection in infants younger than three months of age: a serious childhood disease. Rev Infect Dis 1983; 5: 1019–32.
Amstey, MS, Miller, KR, Menegus, AM, di Sant’Agnese, PA. Enterovirus in the pregnant women in the perfused placenta. Am J Obstet Gynecol 1988; 158: 775–82.
Bates, HR. Coxsackievirus B3 calcific pancarditis and hydrops fetalis. Am J Obstet Gynecol 1970; 106: 629–30.
Strong, BS, Young, SA. Intrauterine coxsackievirus group B type 1 infection: viral cultivation from amniotic fluid in the third trimester. Am J Perinatol 1995; 12: 78–9.
Reyes, MP, Zalenski, D, Smith, F, Wilson, FM, Lerner, AM. Coxsackievirus-positive cervices in women with febrile illness during the third trimester in pregnancy. Am J Obstet Gynecol 1986; 155: 159–61.
Brown, GC, Karunas, RS. Relationship of congenital anomalies and maternal infection with selected enteroviruses. Am J Epidemiol 1972; 95: 207–17.
Gauntt, CJ, Gudvangen, RJ, Brans, YW, Marlin, AE. Coxsackievirus group B antibodies in the ventricular fluid of infants with severe anatomic defects in the central nervous system. Pediatrics 1985; 76: 64–8.
Nathenson, G, Spigland, I, Eisenberg, R. Benign neonatal arrhythmias and coxsackie B virus infection. J Pediatr 1975; 86: 152–3.
Murray, D, Altschul, M, Dyke, J. Aseptic meningitis in a neonate with an oral vesicular lesion. Diagn Microbiol Infect Dis 1985; 3: 77–80.
Theodoridou, M, Kakourou, T, Laina, I, Mostrou, G, Tsakris, A. Vesiculopapular rash as a single presentation in intrauterine coxsackie virus infection. Eur J Pediatr 2002; 161: 412–13.
Euscher, E, Davis, J, Holzman, I, Nuovo, GJ. Coxsackie virus infection of the placenta associated with neurodevelopmental delays in the newborn. Obstet Gynecol 2001; 98: 1019–26.
Hurley, R, Norman, AP, Pryse-Davies, J. Massive pulmonary haemorrhage in the newborn associated with coxsackie B virus infection. Br Med J 1969; 3: 636–7.
Gear, JHS. Coxsackievirus infections in Southern Africa. Yale J Biol Med 1961/1962; 34: 289–96.
Burch, GE, Sun, SC, Chu, KC, Sohal, RS, Colcolough, HL. Interstitial and coxsackievirus B myocarditis in infants and children: a comparative histologic and immunofluorescent study of 50 autopsied hearts. JAMA 1968; 203: 1–8.
Overall, JC. Intrauterine virus infections and congenital heart disease. Am Heart J 1972; 84: 823–33.
Abzug, MJ. Prognosis for neonates with enterovirus hepatitis and coagulopathy. Pediatr Infect Dis J 2001; 20: 758–63.
Rantakallio, P, Jones, P, Moring, J, von Wendt, L. Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up. Int J Epidemiol 1997; 26: 837–43.
Farmer, K, MacArthur, BA, Clay, MM. A follow-up study of 15 cases of neonatal meningoencephalitis due to coxsackie virus B5. J Pediatr 1975; 87: 568–71.
Drash, A. The etiology of diabetes mellitus. N Engl J Med 1979; 300: 1211–13.
Dahlquist, GG, Ivarsson, S, Lindberg, B, Forsgren, M. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. Diabetes 1995; 44: 408–13.
Hyöty, H, Hiltunen, M, Knip, M, et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 1995; 44: 652–7.
Füchtenbusch, M, Irnstetter, A, Jäger, G, Ziegler, AG. No evidence for an association of coxsackievirus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes. J Autoimmun 2001; 17: 333–40.
Viskari, HR, Roivainen, M, Reunanen, A, et al. Maternal first-trimester enterovirus infection and future risk of type 1 diabetes in the exposed fetus. Diabetes 2002; 51: 2568–71.
Balduzzi, PC, Greendyke, RM. Sudden unexpected death in infancy and viral infection. Pediatrics 1966; 38: 201–6.
Gold, E, Carver, DH, Heineberg, H, Adelson, L, Robbins, FC. Viral infection: a possible cause of sudden, unexpected death in infants. N Engl J Med 1961; 264: 53–5.
Valdes-Dapena, MA, Hummeler, K. Sudden and unexpected death in infants. II. Viral infections as causative factors. J Pediatr 1963; 63: 398–401.
Lapinleimu, K, Kaski, U. An outbreak caused by coxsackie B5 among newborn infants. Scand J Infect Dis 1987; 4: 27–30.
Borulf, S, Walder, M, Ulmsten, U. Outbreak of coxsackie virus A14 meningitis among newborns in a maternity hospital ward. Acta Paediatr Scand 1987; 76: 234–8.
Brightman, VJ, McNair, STF, Westphal, M, Boggs, TR. An outbreak of coxsackie B5 virus infection in a newborn nursery. J Pediatr 1966; 69: 179–92.
Hammond, GW, Lukes, H, Wells, B, et al. Maternal and neonatal neutralizing antibody titers to selected enteroviruses. Pediatr Infect Dis 1985; 4: 32–5.
Abzug, MJ, Keyserling, HL, Lee, ML, Rotbart, HA. Neonatal enterovirus infection: virology, serology, and effect of intravenous immune globulin. Clin Infect Dis 1995; 20: 1201–6.
Abzug, MJ, Cloud, G, Bradley, J, et al. Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Pediatr Infect Dis J 2003; 22: 335–41.
Abzug, MJ, Michaels, MG, Wald, E, et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis. J Pediatric Infect Dis Soc 2016; 5: 53–62.
Nagington, J, Gandy, G, Walker, J, Gray, JJ. Use of normal immunoglobulin in an echovirus 11 outbreak in a special-care baby unit. Lancet 1983; 2: 443–6.
Chapman, NM, Ragland, A, Leser, JS, et al. A group B coxsackievirus/poliovirus 5′ nontranslated region chimera can act as an attenuated vaccine strain in mice. J Virol 2000; 74: 4047–56.
Liang, ZL, Mao, QY, Wang, YP, et al. Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccin Immunother 2013; 9: 1701–5.
Zhu, FC, Meng, FY, Li, JX, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2013; 381: 2024–32.
de Villiers, EM, Fauquet, C, Broker, TR, Bernard, HU, zur Hausen, H. Classification of papillomaviruses. Virology 2004; 324: 17–27.
zur Hausen, H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994; 186: 131–56.
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 99: management of abnormal cervical cytology and histology. Obstet Gynecol 2008; 112: 1419–44.
American College of Obstetricians and Gynecologists. Practice Bulletin No. 140: management of abnormal cervical cancer screening test results and cervical cancer precursors. Obstet Gynecol 2013; 122: 1338–67.
Trottier, H, Franco, EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006; 24 (Suppl 1): S1–15.
Kemp, EA, Hakenewerth, AM, Laurent, SL, Gravitt, PE, Stoerker, J. Human papillomavirus prevalence in pregnancy. Obstet Gynecol 1992; 79: 649–56.
Smith, EM, Johnson, SR, Cripe, T, et al. Perinatal transmission and maternal risks of human papillomavirus infection. Cancer Detect Prev 1995; 19: 196–205.
Kjellberg, L, Hallmans, G, Ahren, AM, et al. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intraepithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 2000; 82: 1332–8.
Schneider, A, Hotz, M, Gissmann, L. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer 1987; 40: 198–201.
Rando, RF, Lindheim, S, Hasty, L, et al. Increased frequency of detection of human papillomavirus DNA in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol 1989; 161: 50–4.
Sedlaceck, TV, Lindheim, S, Eder, C. Mechanism for human papillomavirus transmission at birth. Am J Obstet Gynecol 1989; 161: 55–9.
Kashima, HK, Shah, K. Recurrent respiratory papillomatosis: clinical overview and management principles. Obstet Gynecol Clin North Am 1987; 14: 581–8.
Hallden, C, Majmudar, B. The relationship between juvenile laryngeal papillomatosis and maternal condylomata acuminata. J Reprod Med 1986; 31: 804–7.
Milczuk, HA. Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children. Otolaryngol Head Neck Surg 2003; 128: 788–94.
Auborn, KJ. Therapy for recurrent respiratory papillomatosis. Antivir Ther 2002; 7: 1–9.
Allen, AL, Siegfried, EC. The natural history of condylomas in children. J Am Acad Dermatol 1998; 39: 951–5.
Markowitz, LE, Dunne, EF, Saraiya, M, et al.; Centers for Disease Control and Prevention (CDC). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56 (RR-2): 1–24.
Tenti, P, Zappatore, R, Migliora, P, et al. Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet Gynecol 1999; 93: 475–9.
Armbruster-Moraes, E, Ioshimoto, LM, Leao, E, Zugaib, M. Presence of human papillomavirus DNA in amniotic fluids of pregnant women with cervical lesions. Gynecol Oncol 1994; 54: 152–8.
Watts, DH, Koutsky, LA, Holmes, KK, et al. Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol 1998; 178: 365–73.
Sarkola, ME, Grénman, SE, Rintala, MA, Syrjänen, KJ, Syrjänen, SM. Human papillomavirus in the placenta and umbilical cord blood. Acta Obstet Gynecol Scand 2008; 87: 1181–8.
Rombaldi, RL, Serafini, EP, Mandelli, J, Zimmermann, E, Losquiavo, KP. Transplacental transmission of human papillomavirus. Virol J 2008; 5: 106.
Cason, J, Kaye, JN, Jewers, RJ, et al. Perinatal infection and persistence of human papillomavirus 16 and 18 in infants. J Med Virol 1995; 47: 209–18.
Smith, EM, Johnson, SR, Cripe, TP, Pignatari, S, Turek, L. Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. Ann Otol Rhinol Laryngol 1991; 100: 479–83.
Favre, M, Majewski, S, De Jesus, N, et al. A possible vertical transmission of human papillomavirus genotypes associated with epidermodysplasia verruciformis. J Invest Dermatol 1998; 111: 333–6.
Tseng, CJ, Liang, CC, Soong, YK, Pao, CC. Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery. Obstet Gynecol 1998; 91: 92–6.
Tseng, CJ, Lin, CY, Wang, RL, et al. Possible transplacental transmission of human papillomavirus. Am J Obstet Gynecol 1992; 166: 35–40.
Lawton, B, Howe, AS, Turner, N, et al. Association of prior HPV vaccination with reduced preterm birth: a population based study. Vaccine 2018; 36: 134–40. doi: 10.1016/j.vaccine.2017.11.020.
Committee Opinion No. 641. Human papillomavirus vaccination. Obstet Gynecol 2015; 126: e38–43.
Petrosky, E, Bocchini, JA, Hariri, S, et al.; Centers for Disease Control and Prevention (CDC). Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2015; 64: 300–4.
Markowitz, LE, Dunne, EF, Saraiya, M, et al.; Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014; 63 (RR-05): 1–30.
FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356: 1915–27.
Descamps, D, Hardt, K, Spiessens, B, et al. Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials. Hum Vaccin 2009; 5: 332–40.
Einstein, MH, Takacs, P, Chatterjee, A, et al.; HPV-010 Study Group. Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a phase III randomized trial. Hum Vaccin Immunother 2014; 10: 3435–45.
Castellsagué, X, Muñoz, N, Pitisuttithum, P, et al. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age. Br J Cancer 2011; 105: 28–37.
Guevara, AM, Suarez, E, Victoria, A, et al. Maternal transfer of anti HPV 6 and 11 antibodies upon immunization with the 9-valent HPV vaccine. Hum Vaccin Immunother 2019; 15: 141–5. https://doi.org/10.1080/21645515.2018.1514227.
Eskelinen, A, Mashkilleyson, N. Optimum treatment of genital warts. Drugs 1987; 34: 599–603.
Piper, JM, Wen, TT, Xenakis, EM. Interferon therapy in primary care. Prim Care Update Obstet Gynecol 2001; 8: 163–9.
Schwartz, DB, Greenberg, MD, Daoud, Y, Reid, R. Genital condylomas in pregnancy: use of trichloroacetic acid and laser therapy. Am J Obstet Gynecol 1988; 158: 1407–16.
Snoeck, R, Bossens, M, Parent, D, et al. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection. Clin Infect Dis 2001; 33: 597–602.